Study will advance into expanded patient populations with myelodysplastic syndrome (MDS) and myelofibrosis (MF) SOUTH SAN FRANCISCO, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdin ...
Tectonic Therapeutic is reviving relaxin biology with TX45, targeting Group 2 Pulmonary Hypertension with HFpEF. Check out ...
Thousands of Ford Ranger pickup trucks are being recalled for a wiring issue that could result in a fire or risk of a crash. ...
Climb Bio, Inc. stays a Buy on budoprutug pMN data; Phase 2 PrisMN readout 2H 2026 + SLE/ITP upside and 2028 cash runway.
Marion residents are seeing toilet paper on streets due to sewer overflows. The city's 25-year, $95 million project aims to ...
ORION CORPORATION PRESS RELEASE 23 APRIL 2026 at 09.00 EEST Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients ...
Stop overpaying for idle GPUs by splitting your LLM workload into prompt and generation pools. It’s like giving your AI its ...
San Clemente officials want to clarify who can argue for and against a sales tax hike for beach erosion and wildfire ...
A Goldman Sachs veteran says this platform would have funded faster as a rectal drug. Merck disagreed. Here's what took so ...
A voter turnout of 91.58% was recorded in Bengal Phase 1 polls on Thursday. The day saw reports of violence coming from ...
More than 90% of drugs entering clinical trials fail. Behind that statistic sits a stark economic reality: billions of ...
Have you ever heard of the Silent Knight? It was a unique engine that ditched noisy valves for a weirder, quieter, and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results